NCT05527834View on ClinicalTrials.gov

Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

February 6, 2023

Study Completion Date

February 10, 2023

Conditions
Pharmacokinetics
Interventions
DRUG

VNRX-7145

Single oral dose

DRUG

Ceftibuten

Single oral dose

Trial Locations (1)

66219

ICON Plc., Lenaxa

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Venatorx Pharmaceuticals, Inc.

INDUSTRY